The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viscosupplementation for Knee Osteoarthritis Market Research Report 2024
Synopsis
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global Viscosupplementation for Knee Osteoarthritis market was valued at US$ 1822.1 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
A significant driver in the hyaluronic acid injections for joint pain market is the rising prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Hyaluronic acid injections offer pain relief and improved joint function for individuals suffering from joint pain and osteoarthritis, making them a popular choice. However, a notable challenge in this market is the need for evidence-based research and reimbursement issues. Ensuring the effectiveness of hyaluronic acid injections through clinical studies and addressing reimbursement challenges can be barriers to broader market acceptance. Manufacturers and healthcare providers must collaborate to demonstrate the clinical benefits and cost-effectiveness of these injections to meet the demands of patients seeking non-surgical joint pain management solutions.
This report aims to provide a comprehensive presentation of the global market for Viscosupplementation for Knee Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viscosupplementation for Knee Osteoarthritis.
Report Scope
The Viscosupplementation for Knee Osteoarthritis market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viscosupplementation for Knee Osteoarthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viscosupplementation for Knee Osteoarthritis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Viscosupplementation for Knee Osteoarthritis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Viscosupplementation for Knee Osteoarthritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
The global Viscosupplementation for Knee Osteoarthritis market was valued at US$ 1822.1 million in 2023 and is anticipated to reach US$ 2329.4 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
A significant driver in the hyaluronic acid injections for joint pain market is the rising prevalence of osteoarthritis and the growing demand for non-surgical treatment options. Hyaluronic acid injections offer pain relief and improved joint function for individuals suffering from joint pain and osteoarthritis, making them a popular choice. However, a notable challenge in this market is the need for evidence-based research and reimbursement issues. Ensuring the effectiveness of hyaluronic acid injections through clinical studies and addressing reimbursement challenges can be barriers to broader market acceptance. Manufacturers and healthcare providers must collaborate to demonstrate the clinical benefits and cost-effectiveness of these injections to meet the demands of patients seeking non-surgical joint pain management solutions.
This report aims to provide a comprehensive presentation of the global market for Viscosupplementation for Knee Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viscosupplementation for Knee Osteoarthritis.
Report Scope
The Viscosupplementation for Knee Osteoarthritis market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viscosupplementation for Knee Osteoarthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viscosupplementation for Knee Osteoarthritis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Viscosupplementation for Knee Osteoarthritis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Viscosupplementation for Knee Osteoarthritis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Viscosupplementation for Knee Osteoarthritis Market Overview
1.1 Product Overview and Scope of Viscosupplementation for Knee Osteoarthritis
1.2 Viscosupplementation for Knee Osteoarthritis Segment by Type
1.2.1 Global Viscosupplementation for Knee Osteoarthritis Market Value Comparison by Type (2024-2030)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Viscosupplementation for Knee Osteoarthritis Segment by Application
1.3.1 Global Viscosupplementation for Knee Osteoarthritis Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Viscosupplementation for Knee Osteoarthritis Market Size Estimates and Forecasts
1.4.1 Global Viscosupplementation for Knee Osteoarthritis Revenue 2019-2030
1.4.2 Global Viscosupplementation for Knee Osteoarthritis Sales 2019-2030
1.4.3 Global Viscosupplementation for Knee Osteoarthritis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Viscosupplementation for Knee Osteoarthritis Market Competition by Manufacturers
2.1 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Viscosupplementation for Knee Osteoarthritis Average Price by Manufacturers (2019-2024)
2.4 Global Viscosupplementation for Knee Osteoarthritis Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Viscosupplementation for Knee Osteoarthritis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Viscosupplementation for Knee Osteoarthritis, Product Type & Application
2.7 Viscosupplementation for Knee Osteoarthritis Market Competitive Situation and Trends
2.7.1 Viscosupplementation for Knee Osteoarthritis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Viscosupplementation for Knee Osteoarthritis Players Market Share by Revenue
2.7.3 Global Viscosupplementation for Knee Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Viscosupplementation for Knee Osteoarthritis Retrospective Market Scenario by Region
3.1 Global Viscosupplementation for Knee Osteoarthritis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Viscosupplementation for Knee Osteoarthritis Global Viscosupplementation for Knee Osteoarthritis Sales by Region: 2019-2030
3.2.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Region: 2019-2024
3.2.2 Global Viscosupplementation for Knee Osteoarthritis Sales by Region: 2025-2030
3.3 Global Viscosupplementation for Knee Osteoarthritis Global Viscosupplementation for Knee Osteoarthritis Revenue by Region: 2019-2030
3.3.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region: 2019-2024
3.3.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Region: 2025-2030
3.4 North America Viscosupplementation for Knee Osteoarthritis Market Facts & Figures by Country
3.4.1 North America Viscosupplementation for Knee Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Viscosupplementation for Knee Osteoarthritis Sales by Country (2019-2030)
3.4.3 North America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Viscosupplementation for Knee Osteoarthritis Market Facts & Figures by Country
3.5.1 Europe Viscosupplementation for Knee Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Viscosupplementation for Knee Osteoarthritis Sales by Country (2019-2030)
3.5.3 Europe Viscosupplementation for Knee Osteoarthritis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viscosupplementation for Knee Osteoarthritis Market Facts & Figures by Country
3.6.1 Asia Pacific Viscosupplementation for Knee Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Viscosupplementation for Knee Osteoarthritis Sales by Country (2019-2030)
3.6.3 Asia Pacific Viscosupplementation for Knee Osteoarthritis Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Viscosupplementation for Knee Osteoarthritis Market Facts & Figures by Country
3.7.1 Latin America Viscosupplementation for Knee Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Viscosupplementation for Knee Osteoarthritis Sales by Country (2019-2030)
3.7.3 Latin America Viscosupplementation for Knee Osteoarthritis Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Market Facts & Figures by Country
3.8.1 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Viscosupplementation for Knee Osteoarthritis Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2019-2030)
4.1.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2019-2024)
4.1.2 Global Viscosupplementation for Knee Osteoarthritis Sales by Type (2025-2030)
4.1.3 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Type (2019-2030)
4.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2019-2030)
4.2.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2019-2024)
4.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Type (2025-2030)
4.2.3 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Type (2019-2030)
4.3 Global Viscosupplementation for Knee Osteoarthritis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2019-2030)
5.1.1 Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2019-2024)
5.1.2 Global Viscosupplementation for Knee Osteoarthritis Sales by Application (2025-2030)
5.1.3 Global Viscosupplementation for Knee Osteoarthritis Sales Market Share by Application (2019-2030)
5.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2019-2030)
5.2.1 Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2019-2024)
5.2.2 Global Viscosupplementation for Knee Osteoarthritis Revenue by Application (2025-2030)
5.2.3 Global Viscosupplementation for Knee Osteoarthritis Revenue Market Share by Application (2019-2030)
5.3 Global Viscosupplementation for Knee Osteoarthritis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Anika Therapeutics Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Seikagaku Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zimmer Biomet Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bioventus Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Chem Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Freda Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Haohai Biological Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Viscosupplementation for Knee Osteoarthritis Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Jingfeng Viscosupplementation for Knee Osteoarthritis Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viscosupplementation for Knee Osteoarthritis Industry Chain Analysis
7.2 Viscosupplementation for Knee Osteoarthritis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viscosupplementation for Knee Osteoarthritis Production Mode & Process
7.4 Viscosupplementation for Knee Osteoarthritis Sales and Marketing
7.4.1 Viscosupplementation for Knee Osteoarthritis Sales Channels
7.4.2 Viscosupplementation for Knee Osteoarthritis Distributors
7.5 Viscosupplementation for Knee Osteoarthritis Customers
8 Viscosupplementation for Knee Osteoarthritis Market Dynamics
8.1 Viscosupplementation for Knee Osteoarthritis Industry Trends
8.2 Viscosupplementation for Knee Osteoarthritis Market Drivers
8.3 Viscosupplementation for Knee Osteoarthritis Market Challenges
8.4 Viscosupplementation for Knee Osteoarthritis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
